摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

hydroxo(meso-tetrakis(2,6-difluorophenyl)porphirinato)iron(III) | 98716-00-8

中文名称
——
中文别名
——
英文名称
hydroxo(meso-tetrakis(2,6-difluorophenyl)porphirinato)iron(III)
英文别名
tetrakis(2,6-difluorophenylporphinato)hydroxoiron(III);(tetrakis(2,6-difluorophenyl)porphyrinate)Fe(III)OH;hydroxo(5,10,15,20-tetrakis(2,6-difluorophenyl)porphyrinato)iron(III);(5,10,15,20-tetrakis(2,6-difluorophenyl)porphyrin(2-))Fe(III)(OH);[Fe(III)(hydroxo)(tetrakis(2,6-difluorophenyl)porphyrinato)];[Fe(OH)(tetrakis(2,6-difluorophenyl)porphyrinate(2-))]
hydroxo(meso-tetrakis(2,6-difluorophenyl)porphirinato)iron(III)化学式
CAS
98716-00-8
化学式
C44H21F8FeN4O
mdl
——
分子量
829.511
InChiKey
IQVQOGDJXZWWDG-TXFZNMFQSA-M
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    None
  • 重原子数:
    None
  • 可旋转键数:
    None
  • 环数:
    None
  • sp3杂化的碳原子比例:
    None
  • 拓扑面积:
    None
  • 氢给体数:
    None
  • 氢受体数:
    None

反应信息

  • 作为反应物:
    描述:
    hydroxo(meso-tetrakis(2,6-difluorophenyl)porphirinato)iron(III) 在 Na2S2O4 作用下, 以 二氯甲烷 为溶剂, 以72%的产率得到(5,10,15,20-tetrakis(2,6-difluorophenyl)porphyrinate)FeII
    参考文献:
    名称:
    Oxo- and Hydroxo-Bridged Heme-Copper Assemblies Formed from Acid−Base or Metal−Dioxygen Chemistry
    摘要:
    The iron-copper dinuclear active site in heme-copper oxidases (e.g., cyctochrome c oxidase) has spurred the development of the inorganic: chemistry of bridged heme-copper complexes, including species possessing (porphyrinate)Fe-III-O(H)-Cu-II-L moieties. We describe here the synthesis, by two routes, of [(F8TPP)Fe-III-O-Cu-II(MePY2)](+) (5) {F8TPP = tetrakis(2,6-difluorophenyl)porphyrinate; MePY2 = N,N-bis[2-(2-pyridyl)ethyl] methylamine). First, 5-(CF3SO3) was generated by reaction of [(MePY2)Cu-II](CF3SO3)(2) (3-(CF3SO3)(2)) and [(F8TPP)Fe-III-OH] (4) with triethylamine in THF or CH3CN in 65-70% yield. The complex was also prepared by reduction of O-2 by a 1:1 mixture of copper(I) and iron(II) complexes, [(MePY2)Cu-I(CH3CN)](BArF) (1-(BArF)) (BArF = tetrakis(3,5-bis-trifluoromethylphenyl)borate) and (F8TPP)Fe-II (2) in O-2-saturated THF or acetone, at -80 degrees C with subsequent warming to room temperature. Preliminary stopped-flow kinetics on the O-2 reaction with the 1:1 mixture show the formation of at least two intermediates (i.e., a superoxo species (F8TPP)Fe-O-2 first, and then a presumed peroxo-bridged Fe-O-2-Cu species) prior to the formation of the final mu-oxo complex [(F8TPP)Fe-III-O-Cu-II(MePY2)](+) (5-(BArF)). The H-1 NMR spectrum of 5-(CF3SO3) in CD2Cl2 exhibits a pyrrole peak at 67.7 ppm (corroborated by H-2 NMR), while downfield (23.4 and 18.9 ppm) and dramatically upfield-shifted resonances (-87.7, -155.4 and -189.4) have been assigned to hydrogens of the MePY2 moiety, by specific deuteration. The mu-hydroxo complex [(F8TPP)Fe-(OH)-Cu(MePY2)](OTf)(2) (6-(CF3SO3)(2)) was synthesized by addition of 3-(CF3SO3)(2) to 4 in CH3CN, or by protonation of 5-(CF3SO3) with CF3SO3H. In a H-1. NMR-spectroscopic protonation titration (CF3SO3H)(2) the pyrrole 67.7 ppm resonance for 5-(CF3SO3) progressively converts to 70.3 ppm, diagnostic of 6-(CF3SO3)(2). The protonation is slow on the NMR time scale. The H-1 NMR spectral properties are consistent with antiferromagnetically coupled high-spin iron(III) and Cu(II) ions (S = 2 spin state), and the interaction is weaker in 6-(CF3SO3)(2) (5-(CF3SO3), mu(eff) = 5.05 mu(B); 6-(CF3SO3)(2), mu(eff) = 5.60 mu(B); Evans NMR method). By titration using a series of organic acids, the pK(a) for 6-(CF3S03)2 has been estimated to be 16.7 < pK(a) < 17.6 (CH3CN solvent), or 9.6 +/- 2 (aqueous). Plots of delta vs 1/T for both mu-oxo and mu-hydroxo complexes 5-(CF3SO3) and 6-(CF3SO3)(2) have been obtained, showing linear Curie (for downfield resonances) or anti-Curie (for upfield peaks) behavior.
    DOI:
    10.1021/ic981431+
  • 作为产物:
    参考文献:
    名称:
    血红素/O2/•NO 一氧化氮双加氧酶 (NOD) 反应性:通过假定的血红素-过氧亚硝酸盐中间体进行酚类硝化
    摘要:
    氧-血红素复合物,血红素-超氧物种(四氢呋喃)(F(8))Fe(III)-(O(2)(* -))(2)(F(8)=邻二氟取代的四芳基卟啉酸盐), 与一氧化氮 (*NO; 一氧化氮) 反应生成硝基铁 (III) 化合物 (F(8))Fe(III)-(NO(3)(-)) (3) (X 射线)。化学模拟 *NO 双加氧酶 (NOD)、微生物和哺乳动物血红素蛋白的作用,促进 *NO 解毒/体内平衡。涉及过氧亚硝酸盐中间体复合物;如果在 *NO 与 2 反应之前加入 2,4-二叔丁基苯酚,则会发生邻硝化反应,得到 2,4-二叔丁基-6-硝基苯酚。铁产物是 (F(8))Fe(III)-(OH) (4)。结果表明血红素/O(2)/*NO 化学可能导致过氧亚硝酸盐泄漏和/或外源性底物氧化/硝化反应。
    DOI:
    10.1021/ja904832j
点击查看最新优质反应信息

文献信息

  • Heme−Copper−Dioxygen Complexes: Toward Understanding Ligand-Environmental Effects on the Coordination Geometry, Electronic Structure, and Reactivity
    作者:Zakaria Halime、Matthew T. Kieber-Emmons、Munzarin F. Qayyum、Biplab Mondal、Thirumanavelan Gandhi、Simona C. Puiu、Eduardo E. Chufán、Amy A. N. Sarjeant、Keith O. Hodgson、Britt Hedman、Edward I. Solomon、Kenneth D. Karlin
    DOI:10.1021/ic9020993
    日期:2010.4.19
    and more complete electronic description of the high-spin heme−peroxo−copper complexes 1 and 2, which establish μ-(O22−) side-on to the FeIII and end-on to CuII (μ-η2:η1) binding for the complex 1 but side-on/side-on (μ-η2:η2) μ-peroxo coordination for the complex 2. We also compare and summarize the differences and similarities of these two complexes in their reactivity toward CO, PPh3, acid, and phenols
    配体的性质是控制配位化学结构和反应性的一个重要方面。结合我们对与细胞色素c化酶双还原化学相关的血红素--反应性的研究,我们比较了两种高自旋血红素-过- [Fe III O 2 2- Cu II ] +的分子和电子结构含有 N 4四齿 ( 1 ) 或 N 3三齿 ( 2 ) 的配合物) 配体。结合先前报道的和新的共振拉曼和 EXAFS 数据与密度泛函理论计算相结合,我们报告了高自旋血红素-过-配合物1和2的几何结构和更完整的电子描述,它们建立了 μ-(O 2 2 − ) 侧面与 Fe III和端部与 Cu II (μ-η 2 :η 1 ) 结合,与复合物1结合,但侧面/侧面 (μ-η 2 :η 2 ) μ-peroxo复杂2 的协调. 我们还比较和总结了这两种配合物在对 CO、PPh 3、酸和酚类的反应性方面的差异和相似之处。μ-oxo 配合物2a的新 X 射线结构与先前报道的1a
  • Copper–dioxygen reactivity involved in the formation of µ-oxo [(por)Fe<sup>III</sup>–O–Cu<sup>II</sup>L]<sup>+</sup>heterodinuclear complexes (por = porphyrinate, L = tetradentate ligand), and novel synthesis of square-planar Fe<sup>II</sup>(por) species
    作者:Alaganandan Nanthakumar、Stephen Fox、Kenneth D. Karlin
    DOI:10.1039/c39950000499
    日期:——
    In the reaction of FeIII(por) species with [LCuI(KMeCN)]+ and O2 to give µ-oxo [(por)FeIII–O–CuIIL]+3(por = porphyrinate, L = tetradentate ligand), copper–dioxygen adducts or their decomposition products must be present, otherwise [(por)FeIII–OH] or [(por)FeIII–O–FeIII(por)] products appear; a novel synthesis ot square-planar FeII(por) is also described.
    在 FeIII(por) 物种与 [LCuI(KMeCN)]+ 和 O2 的反应中,如果不生成-二化物加合物或其分解产物,则会出现 [(por)FeIII–OH] 或 [(por)FeIII–O–FeIII(por)] 产品;还描述了一种新颖的方形平面 FeII(por) 的合成方法。
  • Generation and Characterization of [(P)M−(X)−Co(TMPA)]<i><sup>n</sup></i><sup>+</sup> Assemblies; P = Porphyrinate, M = Fe<sup>III</sup> and Co<sup>III</sup>, X = O<sup>2</sup><sup>-</sup>, OH<sup>-</sup>, O<sub>2</sub><sup>2</sup><sup>-</sup>, and TMPA = Tris(2-pyridylmethyl)amine
    作者:Eduardo E. Chufán、Claudio N. Verani、Simona C. Puiu、Eva Rentschler、Ulrich Schatzschneider、Christopher Incarvito、Arnold L. Rheingold、Kenneth D. Karlin
    DOI:10.1021/ic061686k
    日期:2007.4.1
    (hydroxo), O22- (peroxo)] complexes, we investigated the effect of cobalt ion substitution for copper or copper and iron. Thus, in this report, the generation and characterization of new mu-oxo, micro-hydroxo, and micro-peroxo (micro-X) assemblies of [(porphyrinate)MIII-X-CoII/III(TMPA)]n+ assemblies is described, where M = FeIII or CoIII and TMPA = tris(2-pyridylmethyl)amine. The mu-oxo complex [(F8TPP)
    利用已建立的桥联[(卟啉)FeIII-X-CuII(配体)] n + [X = O2-(代),OH-(羟基),O22-(过)]配合物的化学性质,我们研究了离子的作用替代。因此,在此报告中,描述了[(卟啉)MIII-X-CoII / III(TMPA)] n +组装体的新型mu-oxo,micro-hydroxo和micro-peroxo(micro-X)组装体的生成和表征,其中M = FeIII或CoIII,TMPA =三(2-吡啶甲基)胺。通过1:1的酸碱自组装反应分离出mu-oxo络合物[(F8TPP)FeIII-O-CoII(TMPA)] +(1,F8TPP =四(2,6-二氟苯基)卟啉加入三乙胺后,(F8TPP)FeIII-OH和[CoII(TMPA)(MeCN)] 2+的混合物。1.2C4H10O的晶体结构证明存在未负载的Fe-O-Co部分。Fe-O-Co角=
  • Inferences from the <sup>1</sup>H-NMR Spectroscopic Study of an Antiferromagnetically Coupled Heterobinuclear Fe(III)−(X)−Cu(II) <i>S</i> = 2 Spin System (X = O<sup>2</sup><sup>-</sup>, OH<sup>-</sup>)
    作者:Alaganandan Nanthakumar、Stephen Fox、Narasimha N. Murthy、Kenneth D. Karlin
    DOI:10.1021/ja962404q
    日期:1997.4.1
    effects of strong antiferromagnetic coupling in the FeIII−X−CuII unit (X = O2-, OH-) of complexes [(F8-TPP)FeIII−O−CuII(TMPA)]+ (1), and [(F8-TPP)FeIII−OH−CuII(TMPA)]+ (2) (F8-TPP = tetrakis(2,6-difluorophenyl)porphyrinate(2−); TMPA = tris(2-pyridylmethyl)amine) are manifested as observable upfield-shifted resonances of the TMPA moiety in the 1H-NMR spectra. The pyrrole resonances appear at 65 and 69 ppm
    本研究考虑了配合物 [(F8-TPP)FeIII-O-CuII(TMPA)]+ ( 1), 和 [(F8-TPP)FeIII-OH-CuII(TMPA)]+ (2) (F8-TPP = 四(2,6-二氟苯基)卟啉酸盐(2-); TMPA = 三(2-吡啶基甲基)胺)在 1H-NMR 光谱中表现为可观察到的 TMPA 部分的高场位移共振。对于 1 和 2,吡咯共振分别出现在 65 和 69 ppm,与源自高自旋 FeIII (S = 5/2) 和 CuII (S = 1/2) 的反磁耦合的 S = 2 基态一致通过桥连配体 X。顺磁性单核配合物 [Co(TMPA)(CH3CN)]2+ (S = 3/2)(X 射线结构报告)和 [Cu(TMPA)(CH3CN)]2+ (S = 1/2) 证明了低场-位移峰与 σ 接触位移机制一致。通过适当合成的甲基化和化衍生物的 1 H 和 2 H NMR
  • XAS Structural Comparisons of Reversibly Interconvertible Oxo- and Hydroxo-Bridged Heme-Copper Oxidase Model Compounds
    作者:Stephen Fox、Alaganandan Nanthakumar、Mårten Wikström、Kenneth D. Karlin、Ninian J. Blackburn
    DOI:10.1021/ja951686b
    日期:1996.1.1
    In this study on model compounds for the iron−copper dinuclear center in heme-copper oxidases, we (i) detail the synthesis and reversible acid−base interconversion of μ-oxo and μ-hydroxo complexes [(F8-TPP)FeIII−(O2-)−CuII(TMPA)]+ (1) and [(F8-TPP)FeIII−(OH-)−CuII(TMPA)]2+ (2) [F8-TPP = tetrakis(2,6-difluorophenyl)porphyrinate(2−), TMPA = tris[(2-pyridylmethyl)amine]; (ii) compare their physical properties;
    在这项关于血红素-化酶中-双核中心模型化合物的研究中,我们(i)详细介绍了 μ-和 μ-羟基复合物 [(F8-TPP)FeIII-( O2-)-CuII(TMPA)]+ (1) 和 [(F8-TPP)FeIII-(OH-)-CuII(TMPA)]2+ (2) [F8-TPP = 四(2,6-二氟苯基)卟啉(2-),TMPA = 三[(2-吡啶甲基)胺];(ii) 比较它们的物理特性;(iii) 使用 XAS(X 射线吸收光谱)建立 2 的结构,这是配体连接性的三体两侧多散射 (MS) 分析的新应用;(iv) 将 2 的 XAS 与 1 和酶制剂的 XAS 进行比较。通过 [(TMPA)CuII(CH3CN)]2+ (3) 和 [(F8-TPP)FeIII-OH] (4) 与三乙胺乙腈中反应制备配合物 1(产率 >70%)。盐 2-(ClO4)2 和 2-(CF3SO3)2 是通过在二氯乙烷中加入
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫